share_log

JMP Securities Reiterates Market Outperform on Terns Pharma, Maintains $15 Price Target

Benzinga ·  Apr 30 12:18

JMP Securities analyst Silvan Tuerkcan reiterates Terns Pharma (NASDAQ:TERN) with a Market Outperform and maintains $15 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment